Risk factors for carbapenem-resistant Klebsiella pneumoniae infection/colonization and predictors of mortality: A retrospective study

Pathogens and Global Health

Volumn 109, Issue 2, 2015, Pages 68-74

  Jiao, Yang ^a   Qin, Yanghua ^a   Liu, Jiajun ^b   Li, Qiang ^a   Dong, Yuchao ^a   Shang, Yan ^a   Huang, Yi ^a   Liu, Rui ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Antimicrobial resistance; Carbapenem resistant Klebsiella pneumoniae; Mortality; Risk factors

Indexed keywords

CEFOPERAZONE PLUS SULBACTAM;

ADULT; AGED; ARTICLE; BACTERIAL COLONIZATION; CARBAPENEM RESISTANT KLEBSIELLA PNEUMONIAE INFECTION; CONTROLLED STUDY; DRUG EXPOSURE; FEMALE; HUMAN; KLEBSIELLA PNEUMONIAE INFECTION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; MULTILOCUS SEQUENCE TYPING; POLYMERASE CHAIN REACTION; PULSED FIELD GEL ELECTROPHORESIS; RETROSPECTIVE STUDY; RISK FACTOR; SEQUENCE HOMOLOGY; TRACHEOSTOMY;

EID: 84963949852     PISSN: 20477724     EISSN: 20477732     Source Type: Journal    
DOI: 10.1179/2047773215Y.0000000004     Document Type: Article

References (35)

1. Han SH. Review of hepatic abscess from Klebsiella pneumoniaeAn association with diabetes mellitus and septic endophthalmitis. West J Med. 1995;162:220-4.
2. Ahmad TA, Haroun M, Hussein AA, El Ashry el SH, El-Sayed LH. Development of a new trend conjugate vaccine for the prevention of Klebsiella pneumoniae. Infect Dis Rep. 2012;4:e33.
3. Neuhauser MM, Weinstein RA, Rydman R, Danziger LH, Karam G, Quinn JP. Antibiotic resistance among gram-negative bacilli in us intensive care units: implications for fluoroquinolone use. JAMA. 2003;289:885-8.
4. Orsi GB, Garcia-Fernandez A, Giordano A, Venditti C, Bencardino A, Gianfreda R, et al. Risk factors and clinical significance of ertapenem-resistant Klebsiella pneumoniae in hospitalised patients. J Hosp Infect. 2011;78:54-8.
5. Won SY, Munoz-Price LS, Lolans K, Hota B, Weinstein RA, Hayden MK. Emergence and rapid regional spread of Klebsiella pneumoniae carbapenemase-producing enterobacteriaceae. Clin Infect Dis. 2011;53:532-40.
6. Hussein K, Raz-Pasteur A, Finkelstein R, Neuberger A, Shachor-Meyouhas Y, Oren I, et al. Impact of carbapenem resistance on the outcome of patients’ hospital-acquired bacteraemia caused by Klebsiella pneumoniae. J Hosp Infect. 2013;83:307-13.
7. MacKenzie FM, Forbes KJ, Dorai-John T, Amyes SG, Gould IM. Emergence of a carbapenem-resistant Klebsiella pneumoniae. Lancet. 1997;350:783.
8. Yigit H, Queenan AM, Anderson GJ, Domenech-Sanchez A, Biddle JW, Steward CD, et al. Novel carbapenem-hydrolyzing beta-lactamase, kpc-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother. 2001;45:1151-61.
9. Kitchel B, Rasheed JK, Patel JB, Srinivasan A, Navon-Venezia S, Carmeli Y, et al. Molecular epidemiology of kpc-producing Klebsiella pneumoniae isolates in the united states: clonal expansion of multilocus sequence type 258. Antimicrob Agents Chemother. 2009;53:3365-70.
10. Rogers BA, Aminzadeh Z, Hayashi Y, Paterson DL. Countryto-country transfer of patients and the risk of multi-resistant bacterial infection. Clin Infect Dis. 2011;53:49-56.
11. Jean S-S, Hsueh P-R. High burden of antimicrobial resistance in asia. Int J Antimicrob Agents. 2011;37:291-5.
12. Kofteridis DP, Valachis A, Dimopoulou D, Maraki S, Christidou A, Mantadakis E, et al. Risk factors for carbapenemresistant Klebsiella pneumoniae infection/colonization: a casecase-control study. J Infect Chemother. 2014;20:293-7.
13. Borer A, Saidel-Odes L, Eskira S, Nativ R, Riesenberg K, Livshiz-Riven I, et al. Risk factors for developing clinical infection with carbapenem-resistant Klebsiella pneumoniae in hospital patients initially only colonized with carbapenemresistant K pneumoniae. Am J Infect Control. 2012;40:421-5.
14. Nguyen M, Eschenauer GA, Bryan M, O’Neil K, Furuya EY, Della-Latta P, et al. Carbapenem-resistant Klebsiella pneumoniae bacteremia: factors correlated with clinical andmicrobiologic outcomes. DiagnMicrobiol Infect Dis. 2010;67:180-4.
15. Orsi GB, Venditti M. Carbapenem-resistant Klebsiella pneumoniae transmission associated to endoscopy. Am J Infect Control. 2013;41:849-50.
16. Kotlovsky T, Shalginov R, Austin L, Sprecher H. Rapid detection of bla KPC-positive Klebsiella pneumoniae in a clinical setting. Eur J Clin Microbiol Infect Dis. 2009;28:309-11.
17. Anderson K, Lonsway D, Rasheed J, Biddle J, Jensen B, McDougal L, et al. Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in enterobacteriaceae. J Clin Microbiol. 2007;45:2723-5.
18. Wikler MA. Performance standards for antimicrobial susceptibility testing: seventeenth informational supplement. Wayne, PA: Clinical and Laboratory Standards Institute; 2007.
19. Cockerill FR. Performance standards for antimicrobial susceptibility testing: twenty-first informational supplement. Wayne, PA: Clinical and Laboratory Standards Institute (CLSI); 2011.
20. Tenover FC, Kalsi RK, Williams PP, Carey RB, Stocker S, Lonsway D, et al. Carbapenem resistance in Klebsiella pneumoniae not detected by automated susceptibility testing. Emer Infect Dis. 2006;12:1209.
21. Gregory CJ, Llata E, Stine N, Gould C, Santiago LM, Vazquez GJ, et al. Outbreak of carbapenem-resistant Klebsiella pneumoniae in puerto rico associated with a novel carbapenemase variant. Infect Control Hosp Epidemiol. 2010;31:476-84.
22. Schwaber MJ, Klarfeld-Lidji S, Navon-Venezia S, Schwartz D, Leavitt A, Carmeli Y. Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob Agents Chemother. 2008;52:1028-33.
23. Zavascki AP, Cruz RP, Goldani LZ. Risk factors for imipenem-resistant Pseudomonas aeruginosa: a comparative analysis of two case-control studies in hospitalized patients. J Hosp Infect. 2005;59:96-101.
24. Lee SO, Kim NJ, Choi SH, Hyong Kim T, Chung JW, Woo JH, et al. Risk factors for acquisition of imipenem-resistant Acinetobacter baumannii: a case-control study. Antimicrob Agents. Chemother. 2004;48:224-8.
25. Kwak YG, Choi SH, Choo EJ, Chung JW, Jeong JY, Kim NJ, et al. Risk factors for the acquisition of carbapenem-resistant Klebsiella pneumoniae among hospitalized patients. Microb Drug Resist. 2005;11:165-9.
26. Gasink LB, Edelstein PH, Lautenbach E, Synnestvedt M, Fishman NO. Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing K. Pneumoniae. Infect Control Hosp Epidemiol. 2009;30:1180-5.
27. Patel G, Huprikar S, Factor SH, Jenkins SG, Calfee DP. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol. 2008;29:1099-106.
28. Orsi G, Bencardino A, Vena A, Carattoli A, Venditti C, Falcone M, et al. Patient risk factors for outer membrane permeability and KPC-producing carbapenem-resistant Klebsiella pneumoniae isolation: results of a double case-control study. Infection. 2013;41:61-7.
29. Gomez Rueda V, Zuleta Tobon JJ. Risk factors for infection with carbapenem-resistant Klebsiella pneumoniae: a case-casecontrol study. Colomb Med (Cali). 2014;45:54-60.
30. Falagas ME, Rafailidis PI, Kofteridis D, Virtzili S, Chelvatzoglou FC, Papaioannou V, et al. Risk factors of carbapenem-resistant Klebsiella pneumoniae infections: a matched case control study. J Antimicrob Chemother. 2007;60:1124-30.
31. Wu D, Cai J, Liu J. Risk factors for the acquisition of nosocomial infection with carbapenem-resistant Klebsiella pneumoniae. South Med J. 2011;104:106-10.
32. Deshpande LM, Fritsche TR, Moet GJ, Biedenbach DJ, Jones RN. Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from north america and europe: a report from the sentry antimicrobial surveillance program. Diagn Microbiol Infect Dis. 2007;58:163-70.
33. Meakins S, Fisher IS, Berghold C, Gerner-Smidt P, Tschape H, Cormican M, et al. Antimicrobial drug resistance in human nontyphoidal salmonella isolates in europe 2000-2004: a report from the enter-net international surveillance network. Microb Drug Resist. 2008;14:31-5.
34. Mavroidi A, Neonakis I, Liakopoulos A, Papaioannou A, Ntala M, Tryposkiadis F, et al. Detection of citrobacter koseri carrying beta-lactamase KPC-2 in a hospitalised patient, Greece. Euro Surveill. 2011;16:2011.
35. Landman D, Bratu S, Quale J. Contribution of ompk36 to carbapenem susceptibility in KPC-producing Klebsiella pneumoniae. J Med Microbiol. 2009;58:1303-8.